Search

Showing "11154" results for ""

HIV testing in Africa: will VCT for all do more than ABC approach?

Treatment with HAART reduces liver-related mortality in HIV/HCV coinfected patients

India to begin free HIV treatment programme, will treat 100,000 within a year

WHO unveils plans to treat 3 million by 2005

d4T/3TC/nevirapine will be preferred option for 3 x 5

Community mobilisation key to success of 3 x 5

HAART patients at greater risk of severe side-effects than AIDS

HAART may cause oxidant stress says US study

HIV-positive rapist gets ten years and has deportation ordered

Is lipodystrophy caused by the action of antiretroviral drugs in the brain?

Main article: Palliative care and symptom management: Palliation vs Diagnosis and Cure

WHO Announces 3 X 5 Plans

Fat loss in all body regions most common form of lipodystrophy in women

NICE issues guidance for England and Wales on hepatitis C treatment

South African drug deal bring $140 a year treatment within reach of African nations

Different resistance patterns seen with subtype C HIV in Brazil

Minority can have CD4 rises and no illness for more than 3 years after treatment failure

Fibre-, protein-, calorie-rich diet appears to protect against central fat gain in men

Receive the latest HIV research and conference news

Showing "11154" results for ""

HIV testing in Africa: will VCT for all do more than ABC approach?

Treatment with HAART reduces liver-related mortality in HIV/HCV coinfected patients

India to begin free HIV treatment programme, will treat 100,000 within a year

WHO unveils plans to treat 3 million by 2005

d4T/3TC/nevirapine will be preferred option for 3 x 5

Community mobilisation key to success of 3 x 5

HAART patients at greater risk of severe side-effects than AIDS

HAART may cause oxidant stress says US study

HIV-positive rapist gets ten years and has deportation ordered

Is lipodystrophy caused by the action of antiretroviral drugs in the brain?

Main article: Palliative care and symptom management: Palliation vs Diagnosis and Cure

WHO Announces 3 X 5 Plans

Fat loss in all body regions most common form of lipodystrophy in women

NICE issues guidance for England and Wales on hepatitis C treatment

South African drug deal bring $140 a year treatment within reach of African nations

Different resistance patterns seen with subtype C HIV in Brazil

Minority can have CD4 rises and no illness for more than 3 years after treatment failure

Fibre-, protein-, calorie-rich diet appears to protect against central fat gain in men

Receive the latest HIV research and conference news